Hidradenitis Suppurativa Area and Severity Index (HASI): a pilot study to develop a novel instrument to measure the physical signs of hidradenitis suppurativa.
作者信息
Goldfarb N, Ingram J R, Jemec G B E, Naik H B, Piguet V, Hyde M J, Freese R, Lowes M A, Alavi A
机构信息
Departments of Medicine and Dermatology, University of Minnesota, Minneapolis, MN, U.S.A.
Departments of Medicine and Dermatology, Minneapolis Veterans Affairs Health Care System, Minneapolis, MN, U.S.A.
出版信息
Br J Dermatol. 2020 Jan;182(1):240-242. doi: 10.1111/bjd.18335. Epub 2019 Sep 17.
Abstract
摘要
相似文献
1
Hidradenitis Suppurativa Area and Severity Index (HASI): a pilot study to develop a novel instrument to measure the physical signs of hidradenitis suppurativa.
Br J Dermatol. 2020 Jan;182(1):240-242. doi: 10.1111/bjd.18335. Epub 2019 Sep 17.
2
Hidradenitis Suppurativa Area and Severity Index Revised (HASI-R): psychometric property assessment.
Br J Dermatol. 2021 May;184(5):905-912. doi: 10.1111/bjd.19565. Epub 2020 Dec 30.
3
Worst area local Hidradenitis suppurativa Activity and Severity Index-Revised (W-HASI-R): a study evaluating construct validity.
Br J Dermatol. 2023 Aug 24;189(3):338-354. doi: 10.1093/bjd/ljad138.
4
Could Residents Adequately Assess the Severity of Hidradenitis Suppurativa? Interrater and Intrarater Reliability Assessment of Major Scoring Systems.
Dermatology. 2020;236(1):8-14. doi: 10.1159/000501771. Epub 2019 Sep 5.
5
Measuring Quality of Life in Hidradenitis Suppurativa: Development and Validation of a Disease-specific Patient-reported Outcome Measure for Practice and Research.
Acta Derm Venereol. 2023 Jan 31;103:adv00859. doi: 10.2340/actadv.v102.2485.
6
Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.
Br J Dermatol. 2019 Sep;181(3):483-491. doi: 10.1111/bjd.17716. Epub 2019 Jun 6.
7
Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
Acta Dermatovenerol Croat. 2021 Jul;29(2):108-110.
8
Pain in Hidradenitis Suppurativa: A Pilot Study.
Acta Derm Venereol. 2016 May;96(4):554-6. doi: 10.2340/00015555-2308.
9
Hidradenitis suppurativa, a review of pathogenesis, associations and management. Part 1.
Australas J Dermatol. 2018 Nov;59(4):267-277. doi: 10.1111/ajd.12770. Epub 2018 Jan 21.
10
Quality of Life in Hidradenitis Suppurativa: validation of the HSQoL-24.
Acta Derm Venereol. 2021 Aug 25;101(8):adv00529. doi: 10.2340/00015555-3905.
引用本文的文献
1
Review of Scoring Systems for Hidradenitis Suppurativa.
Ann Dermatol. 2024 Feb;36(1):9-17. doi: 10.5021/ad.23.090.
2
Overview and comparison of the clinical scores in hidradenitis suppurativa: A real-life clinical data.
Front Med (Lausanne). 2023 Apr 17;10:1145152. doi: 10.3389/fmed.2023.1145152. eCollection 2023.
3
New treatments and new assessment instruments for Hidradenitis suppurativa.
Exp Dermatol. 2022 Sep;31 Suppl 1(Suppl 1):33-39. doi: 10.1111/exd.14609.
4
International Dermatology Outcome Measures (IDEOM): Report from the 2020 Annual Meeting.
Dermatology. 2022;238(3):430-437. doi: 10.1159/000518966. Epub 2021 Sep 17.
5
A survey of clinicians regarding preferred severity assessment tools for hidradenitis suppurativa.
Int J Dermatol. 2021 Jun;60(6):e248-e251. doi: 10.1111/ijd.15295. Epub 2020 Nov 12.
6
Hidradenitis Suppurativa Area and Severity Index Revised (HASI-R): psychometric property assessment.
Br J Dermatol. 2021 May;184(5):905-912. doi: 10.1111/bjd.19565. Epub 2020 Dec 30.
7
The most recent advances in understanding and managing hidradenitis suppurativa.
F1000Res. 2020 Aug 26;9. doi: 10.12688/f1000research.26083.1. eCollection 2020.
本文引用的文献
1
Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.
Br J Dermatol. 2019 Sep;181(3):483-491. doi: 10.1111/bjd.17716. Epub 2019 Jun 6.
2
A Novel Severity Assessment Scoring System for Hidradenitis Suppurativa.
JAMA Dermatol. 2018 Mar 1;154(3):330-335. doi: 10.1001/jamadermatol.2017.5890.
3
Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity.
Br J Dermatol. 2017 Nov;177(5):1401-1409. doi: 10.1111/bjd.15748. Epub 2017 Oct 30.
4
A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research.
J Chiropr Med. 2016 Jun;15(2):155-63. doi: 10.1016/j.jcm.2016.02.012. Epub 2016 Mar 31.
5
Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment.
Br J Dermatol. 2014 Dec;171(6):1434-42. doi: 10.1111/bjd.13270. Epub 2014 Nov 11.
6
Correlation and simple linear regression.
Radiology. 2003 Jun;227(3):617-22. doi: 10.1148/radiol.2273011499.
Zotero 插件